nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0256	0.248	CbGbCtD
Disopyramide—CYP3A4—Triamcinolone—psoriatic arthritis	0.0194	0.188	CbGbCtD
Disopyramide—CYP3A4—Betamethasone—psoriatic arthritis	0.0167	0.161	CbGbCtD
Disopyramide—CYP3A4—Prednisolone—psoriatic arthritis	0.0164	0.159	CbGbCtD
Disopyramide—CYP3A4—Prednisone—psoriatic arthritis	0.0155	0.15	CbGbCtD
Disopyramide—CYP3A4—Dexamethasone—psoriatic arthritis	0.00969	0.0938	CbGbCtD
Disopyramide—Cardiac arrest—Dexamethasone—psoriatic arthritis	0.00422	0.00471	CcSEcCtD
Disopyramide—Cardiac arrest—Betamethasone—psoriatic arthritis	0.00422	0.00471	CcSEcCtD
Disopyramide—Weight increased—Prednisolone—psoriatic arthritis	0.00418	0.00467	CcSEcCtD
Disopyramide—Sweating increased—Triamcinolone—psoriatic arthritis	0.00412	0.00459	CcSEcCtD
Disopyramide—Sweating increased—Methylprednisolone—psoriatic arthritis	0.00411	0.00458	CcSEcCtD
Disopyramide—Coma—Methotrexate—psoriatic arthritis	0.00407	0.00454	CcSEcCtD
Disopyramide—Hypokalaemia—Betamethasone—psoriatic arthritis	0.00404	0.00451	CcSEcCtD
Disopyramide—Hypokalaemia—Dexamethasone—psoriatic arthritis	0.00404	0.00451	CcSEcCtD
Disopyramide—Gynaecomastia—Methotrexate—psoriatic arthritis	0.00398	0.00444	CcSEcCtD
Disopyramide—Cardiac failure—Prednisone—psoriatic arthritis	0.00396	0.00442	CcSEcCtD
Disopyramide—Muscular weakness—Betamethasone—psoriatic arthritis	0.00391	0.00437	CcSEcCtD
Disopyramide—Muscular weakness—Dexamethasone—psoriatic arthritis	0.00391	0.00437	CcSEcCtD
Disopyramide—Weight increased—Triamcinolone—psoriatic arthritis	0.00385	0.00429	CcSEcCtD
Disopyramide—Weight increased—Methylprednisolone—psoriatic arthritis	0.00384	0.00428	CcSEcCtD
Disopyramide—Psychotic disorder—Prednisone—psoriatic arthritis	0.00378	0.00421	CcSEcCtD
Disopyramide—Bradycardia—Prednisolone—psoriatic arthritis	0.00375	0.00418	CcSEcCtD
Disopyramide—Sweating increased—Betamethasone—psoriatic arthritis	0.00374	0.00417	CcSEcCtD
Disopyramide—Sweating increased—Dexamethasone—psoriatic arthritis	0.00374	0.00417	CcSEcCtD
Disopyramide—Cardiac arrest—Prednisone—psoriatic arthritis	0.00368	0.0041	CcSEcCtD
Disopyramide—Hypokalaemia—Prednisone—psoriatic arthritis	0.00352	0.00392	CcSEcCtD
Disopyramide—Weight increased—Betamethasone—psoriatic arthritis	0.00349	0.00389	CcSEcCtD
Disopyramide—Weight increased—Dexamethasone—psoriatic arthritis	0.00349	0.00389	CcSEcCtD
Disopyramide—Bradycardia—Triamcinolone—psoriatic arthritis	0.00345	0.00384	CcSEcCtD
Disopyramide—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00344	0.00383	CcSEcCtD
Disopyramide—Muscular weakness—Prednisone—psoriatic arthritis	0.00341	0.0038	CcSEcCtD
Disopyramide—Abdominal distension—Prednisone—psoriatic arthritis	0.00336	0.00375	CcSEcCtD
Disopyramide—Arrhythmia—Prednisolone—psoriatic arthritis	0.00329	0.00367	CcSEcCtD
Disopyramide—Sweating increased—Prednisone—psoriatic arthritis	0.00325	0.00363	CcSEcCtD
Disopyramide—Bradycardia—Dexamethasone—psoriatic arthritis	0.00313	0.00349	CcSEcCtD
Disopyramide—Bradycardia—Betamethasone—psoriatic arthritis	0.00313	0.00349	CcSEcCtD
Disopyramide—Neutropenia—Prednisone—psoriatic arthritis	0.00312	0.00348	CcSEcCtD
Disopyramide—Erectile dysfunction—Prednisone—psoriatic arthritis	0.00308	0.00343	CcSEcCtD
Disopyramide—Weight increased—Prednisone—psoriatic arthritis	0.00304	0.00339	CcSEcCtD
Disopyramide—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00302	0.00337	CcSEcCtD
Disopyramide—Vision blurred—Prednisolone—psoriatic arthritis	0.00302	0.00337	CcSEcCtD
Disopyramide—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.00302	0.00336	CcSEcCtD
Disopyramide—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00297	0.00332	CcSEcCtD
Disopyramide—Depression—Prednisone—psoriatic arthritis	0.00297	0.00331	CcSEcCtD
Disopyramide—Angioedema—Prednisolone—psoriatic arthritis	0.00293	0.00326	CcSEcCtD
Disopyramide—Malaise—Prednisolone—psoriatic arthritis	0.00289	0.00322	CcSEcCtD
Disopyramide—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00288	0.00322	CcSEcCtD
Disopyramide—Vertigo—Prednisolone—psoriatic arthritis	0.00288	0.00321	CcSEcCtD
Disopyramide—Syncope—Prednisolone—psoriatic arthritis	0.00287	0.0032	CcSEcCtD
Disopyramide—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00282	0.00314	CcSEcCtD
Disopyramide—Arrhythmia—Dexamethasone—psoriatic arthritis	0.00274	0.00306	CcSEcCtD
Disopyramide—Arrhythmia—Betamethasone—psoriatic arthritis	0.00274	0.00306	CcSEcCtD
Disopyramide—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00273	0.00305	CcSEcCtD
Disopyramide—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00273	0.00304	CcSEcCtD
Disopyramide—Bradycardia—Prednisone—psoriatic arthritis	0.00272	0.00304	CcSEcCtD
Disopyramide—Discomfort—Prednisolone—psoriatic arthritis	0.00269	0.00301	CcSEcCtD
Disopyramide—Angioedema—Triamcinolone—psoriatic arthritis	0.00269	0.003	CcSEcCtD
Disopyramide—Angioedema—Methylprednisolone—psoriatic arthritis	0.00269	0.003	CcSEcCtD
Disopyramide—Malaise—Triamcinolone—psoriatic arthritis	0.00266	0.00296	CcSEcCtD
Disopyramide—Malaise—Methylprednisolone—psoriatic arthritis	0.00265	0.00296	CcSEcCtD
Disopyramide—Vertigo—Triamcinolone—psoriatic arthritis	0.00265	0.00295	CcSEcCtD
Disopyramide—Syncope—Triamcinolone—psoriatic arthritis	0.00264	0.00295	CcSEcCtD
Disopyramide—Vertigo—Methylprednisolone—psoriatic arthritis	0.00264	0.00295	CcSEcCtD
Disopyramide—Syncope—Methylprednisolone—psoriatic arthritis	0.00264	0.00294	CcSEcCtD
Disopyramide—Oedema—Prednisolone—psoriatic arthritis	0.00261	0.00292	CcSEcCtD
Disopyramide—Dysuria—Methotrexate—psoriatic arthritis	0.00261	0.00291	CcSEcCtD
Disopyramide—Neutropenia—Methotrexate—psoriatic arthritis	0.00261	0.00291	CcSEcCtD
Disopyramide—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00259	0.00289	CcSEcCtD
Disopyramide—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00258	0.00288	CcSEcCtD
Disopyramide—Shock—Prednisolone—psoriatic arthritis	0.00257	0.00287	CcSEcCtD
Disopyramide—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00257	0.00287	CcSEcCtD
Disopyramide—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00253	0.00282	CcSEcCtD
Disopyramide—Drowsiness—Methotrexate—psoriatic arthritis	0.00249	0.00278	CcSEcCtD
Disopyramide—Depression—Methotrexate—psoriatic arthritis	0.00248	0.00277	CcSEcCtD
Disopyramide—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00248	0.00277	CcSEcCtD
Disopyramide—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00248	0.00277	CcSEcCtD
Disopyramide—Discomfort—Triamcinolone—psoriatic arthritis	0.00248	0.00276	CcSEcCtD
Disopyramide—Discomfort—Methylprednisolone—psoriatic arthritis	0.00247	0.00276	CcSEcCtD
Disopyramide—Dry mouth—Triamcinolone—psoriatic arthritis	0.00245	0.00274	CcSEcCtD
Disopyramide—Angioedema—Dexamethasone—psoriatic arthritis	0.00244	0.00272	CcSEcCtD
Disopyramide—Angioedema—Betamethasone—psoriatic arthritis	0.00244	0.00272	CcSEcCtD
Disopyramide—Confusional state—Methylprednisolone—psoriatic arthritis	0.00242	0.0027	CcSEcCtD
Disopyramide—Malaise—Dexamethasone—psoriatic arthritis	0.00241	0.00269	CcSEcCtD
Disopyramide—Malaise—Betamethasone—psoriatic arthritis	0.00241	0.00269	CcSEcCtD
Disopyramide—Oedema—Triamcinolone—psoriatic arthritis	0.0024	0.00268	CcSEcCtD
Disopyramide—Vertigo—Dexamethasone—psoriatic arthritis	0.0024	0.00268	CcSEcCtD
Disopyramide—Vertigo—Betamethasone—psoriatic arthritis	0.0024	0.00268	CcSEcCtD
Disopyramide—Syncope—Betamethasone—psoriatic arthritis	0.0024	0.00267	CcSEcCtD
Disopyramide—Syncope—Dexamethasone—psoriatic arthritis	0.0024	0.00267	CcSEcCtD
Disopyramide—Arrhythmia—Prednisone—psoriatic arthritis	0.00239	0.00266	CcSEcCtD
Disopyramide—Shock—Triamcinolone—psoriatic arthritis	0.00237	0.00264	CcSEcCtD
Disopyramide—Insomnia—Prednisolone—psoriatic arthritis	0.00236	0.00264	CcSEcCtD
Disopyramide—Shock—Methylprednisolone—psoriatic arthritis	0.00236	0.00263	CcSEcCtD
Disopyramide—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00235	0.00262	CcSEcCtD
Disopyramide—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00235	0.00262	CcSEcCtD
Disopyramide—Paraesthesia—Prednisolone—psoriatic arthritis	0.00235	0.00262	CcSEcCtD
Disopyramide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00233	0.0026	CcSEcCtD
Disopyramide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00232	0.00259	CcSEcCtD
Disopyramide—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00232	0.00259	CcSEcCtD
Disopyramide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00232	0.00259	CcSEcCtD
Disopyramide—Discomfort—Betamethasone—psoriatic arthritis	0.00225	0.00251	CcSEcCtD
Disopyramide—Discomfort—Dexamethasone—psoriatic arthritis	0.00225	0.00251	CcSEcCtD
Disopyramide—Hypotension—Methylprednisolone—psoriatic arthritis	0.00224	0.0025	CcSEcCtD
Disopyramide—Pain—Prednisolone—psoriatic arthritis	0.00224	0.00249	CcSEcCtD
Disopyramide—Hepatitis—Methotrexate—psoriatic arthritis	0.00223	0.00249	CcSEcCtD
Disopyramide—Vision blurred—Prednisone—psoriatic arthritis	0.00219	0.00245	CcSEcCtD
Disopyramide—Oedema—Betamethasone—psoriatic arthritis	0.00218	0.00243	CcSEcCtD
Disopyramide—Oedema—Dexamethasone—psoriatic arthritis	0.00218	0.00243	CcSEcCtD
Disopyramide—Insomnia—Triamcinolone—psoriatic arthritis	0.00217	0.00243	CcSEcCtD
Disopyramide—Insomnia—Methylprednisolone—psoriatic arthritis	0.00217	0.00242	CcSEcCtD
Disopyramide—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00216	0.00241	CcSEcCtD
Disopyramide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00216	0.00241	CcSEcCtD
Disopyramide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00215	0.0024	CcSEcCtD
Disopyramide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00215	0.0024	CcSEcCtD
Disopyramide—Shock—Dexamethasone—psoriatic arthritis	0.00215	0.00239	CcSEcCtD
Disopyramide—Shock—Betamethasone—psoriatic arthritis	0.00215	0.00239	CcSEcCtD
Disopyramide—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00214	0.00239	CcSEcCtD
Disopyramide—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00214	0.00238	CcSEcCtD
Disopyramide—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00214	0.00238	CcSEcCtD
Disopyramide—Angioedema—Prednisone—psoriatic arthritis	0.00213	0.00237	CcSEcCtD
Disopyramide—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00212	0.00236	CcSEcCtD
Disopyramide—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00211	0.00236	CcSEcCtD
Disopyramide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00211	0.00235	CcSEcCtD
Disopyramide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00211	0.00235	CcSEcCtD
Disopyramide—Malaise—Prednisone—psoriatic arthritis	0.0021	0.00234	CcSEcCtD
Disopyramide—Vertigo—Prednisone—psoriatic arthritis	0.00209	0.00233	CcSEcCtD
Disopyramide—Syncope—Prednisone—psoriatic arthritis	0.00209	0.00233	CcSEcCtD
Disopyramide—Anorexia—Dexamethasone—psoriatic arthritis	0.00208	0.00232	CcSEcCtD
Disopyramide—Anorexia—Betamethasone—psoriatic arthritis	0.00208	0.00232	CcSEcCtD
Disopyramide—Urticaria—Prednisolone—psoriatic arthritis	0.00208	0.00232	CcSEcCtD
Disopyramide—Fatigue—Triamcinolone—psoriatic arthritis	0.00207	0.00231	CcSEcCtD
Disopyramide—Fatigue—Methylprednisolone—psoriatic arthritis	0.00207	0.00231	CcSEcCtD
Disopyramide—Pain—Triamcinolone—psoriatic arthritis	0.00206	0.00229	CcSEcCtD
Disopyramide—Loss of consciousness—Prednisone—psoriatic arthritis	0.00205	0.00228	CcSEcCtD
Disopyramide—Hypotension—Betamethasone—psoriatic arthritis	0.00204	0.00227	CcSEcCtD
Disopyramide—Hypotension—Dexamethasone—psoriatic arthritis	0.00204	0.00227	CcSEcCtD
Disopyramide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00198	0.00221	CcSEcCtD
Disopyramide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00198	0.0022	CcSEcCtD
Disopyramide—Insomnia—Dexamethasone—psoriatic arthritis	0.00197	0.0022	CcSEcCtD
Disopyramide—Insomnia—Betamethasone—psoriatic arthritis	0.00197	0.0022	CcSEcCtD
Disopyramide—Paraesthesia—Betamethasone—psoriatic arthritis	0.00196	0.00218	CcSEcCtD
Disopyramide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00196	0.00218	CcSEcCtD
Disopyramide—Discomfort—Prednisone—psoriatic arthritis	0.00196	0.00218	CcSEcCtD
Disopyramide—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00192	0.00214	CcSEcCtD
Disopyramide—Dyspepsia—Betamethasone—psoriatic arthritis	0.00192	0.00214	CcSEcCtD
Disopyramide—Urticaria—Triamcinolone—psoriatic arthritis	0.00191	0.00213	CcSEcCtD
Disopyramide—Urticaria—Methylprednisolone—psoriatic arthritis	0.00191	0.00213	CcSEcCtD
Disopyramide—Dysgeusia—Methotrexate—psoriatic arthritis	0.00191	0.00212	CcSEcCtD
Disopyramide—Body temperature increased—Triamcinolone—psoriatic arthritis	0.0019	0.00212	CcSEcCtD
Disopyramide—Oedema—Prednisone—psoriatic arthritis	0.0019	0.00212	CcSEcCtD
Disopyramide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.0019	0.00212	CcSEcCtD
Disopyramide—Decreased appetite—Betamethasone—psoriatic arthritis	0.0019	0.00212	CcSEcCtD
Disopyramide—Fatigue—Dexamethasone—psoriatic arthritis	0.00188	0.0021	CcSEcCtD
Disopyramide—Fatigue—Betamethasone—psoriatic arthritis	0.00188	0.0021	CcSEcCtD
Disopyramide—Shock—Prednisone—psoriatic arthritis	0.00187	0.00208	CcSEcCtD
Disopyramide—Pain—Betamethasone—psoriatic arthritis	0.00187	0.00208	CcSEcCtD
Disopyramide—Pain—Dexamethasone—psoriatic arthritis	0.00187	0.00208	CcSEcCtD
Disopyramide—Skin disorder—Prednisone—psoriatic arthritis	0.00185	0.00206	CcSEcCtD
Disopyramide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00184	0.00205	CcSEcCtD
Disopyramide—Vision blurred—Methotrexate—psoriatic arthritis	0.00183	0.00204	CcSEcCtD
Disopyramide—Anorexia—Prednisone—psoriatic arthritis	0.00181	0.00202	CcSEcCtD
Disopyramide—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00181	0.00201	CcSEcCtD
Disopyramide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.0018	0.00201	CcSEcCtD
Disopyramide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.0018	0.00201	CcSEcCtD
Disopyramide—Malaise—Methotrexate—psoriatic arthritis	0.00175	0.00196	CcSEcCtD
Disopyramide—Vertigo—Methotrexate—psoriatic arthritis	0.00175	0.00195	CcSEcCtD
Disopyramide—Urticaria—Dexamethasone—psoriatic arthritis	0.00173	0.00193	CcSEcCtD
Disopyramide—Urticaria—Betamethasone—psoriatic arthritis	0.00173	0.00193	CcSEcCtD
Disopyramide—Dizziness—Prednisolone—psoriatic arthritis	0.00173	0.00193	CcSEcCtD
Disopyramide—Asthenia—Triamcinolone—psoriatic arthritis	0.00173	0.00192	CcSEcCtD
Disopyramide—Body temperature increased—Betamethasone—psoriatic arthritis	0.00172	0.00192	CcSEcCtD
Disopyramide—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00172	0.00192	CcSEcCtD
Disopyramide—Asthenia—Methylprednisolone—psoriatic arthritis	0.00172	0.00192	CcSEcCtD
Disopyramide—Insomnia—Prednisone—psoriatic arthritis	0.00172	0.00192	CcSEcCtD
Disopyramide—Paraesthesia—Prednisone—psoriatic arthritis	0.00171	0.0019	CcSEcCtD
Disopyramide—Pruritus—Triamcinolone—psoriatic arthritis	0.0017	0.0019	CcSEcCtD
Disopyramide—Pruritus—Methylprednisolone—psoriatic arthritis	0.0017	0.00189	CcSEcCtD
Disopyramide—Dyspepsia—Prednisone—psoriatic arthritis	0.00167	0.00187	CcSEcCtD
Disopyramide—Chest pain—Methotrexate—psoriatic arthritis	0.00166	0.00185	CcSEcCtD
Disopyramide—Decreased appetite—Prednisone—psoriatic arthritis	0.00165	0.00184	CcSEcCtD
Disopyramide—Rash—Prednisolone—psoriatic arthritis	0.00165	0.00184	CcSEcCtD
Disopyramide—Dermatitis—Prednisolone—psoriatic arthritis	0.00165	0.00184	CcSEcCtD
Disopyramide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00164	0.00183	CcSEcCtD
Disopyramide—Fatigue—Prednisone—psoriatic arthritis	0.00164	0.00183	CcSEcCtD
Disopyramide—Headache—Prednisolone—psoriatic arthritis	0.00164	0.00183	CcSEcCtD
Disopyramide—Discomfort—Methotrexate—psoriatic arthritis	0.00164	0.00183	CcSEcCtD
Disopyramide—Constipation—Prednisone—psoriatic arthritis	0.00162	0.00181	CcSEcCtD
Disopyramide—Confusional state—Methotrexate—psoriatic arthritis	0.0016	0.00179	CcSEcCtD
Disopyramide—Dizziness—Triamcinolone—psoriatic arthritis	0.00159	0.00177	CcSEcCtD
Disopyramide—Dizziness—Methylprednisolone—psoriatic arthritis	0.00159	0.00177	CcSEcCtD
Disopyramide—Feeling abnormal—Prednisone—psoriatic arthritis	0.00157	0.00175	CcSEcCtD
Disopyramide—Asthenia—Betamethasone—psoriatic arthritis	0.00157	0.00175	CcSEcCtD
Disopyramide—Asthenia—Dexamethasone—psoriatic arthritis	0.00157	0.00175	CcSEcCtD
Disopyramide—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00155	0.00173	CcSEcCtD
Disopyramide—Nausea—Prednisolone—psoriatic arthritis	0.00155	0.00173	CcSEcCtD
Disopyramide—Pruritus—Dexamethasone—psoriatic arthritis	0.00154	0.00172	CcSEcCtD
Disopyramide—Pruritus—Betamethasone—psoriatic arthritis	0.00154	0.00172	CcSEcCtD
Disopyramide—Skin disorder—Methotrexate—psoriatic arthritis	0.00154	0.00172	CcSEcCtD
Disopyramide—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00153	0.00171	CcSEcCtD
Disopyramide—Vomiting—Triamcinolone—psoriatic arthritis	0.00153	0.00171	CcSEcCtD
Disopyramide—Vomiting—Methylprednisolone—psoriatic arthritis	0.00153	0.0017	CcSEcCtD
Disopyramide—Rash—Triamcinolone—psoriatic arthritis	0.00152	0.00169	CcSEcCtD
Disopyramide—Dermatitis—Triamcinolone—psoriatic arthritis	0.00151	0.00169	CcSEcCtD
Disopyramide—Anorexia—Methotrexate—psoriatic arthritis	0.00151	0.00169	CcSEcCtD
Disopyramide—Rash—Methylprednisolone—psoriatic arthritis	0.00151	0.00169	CcSEcCtD
Disopyramide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00151	0.00169	CcSEcCtD
Disopyramide—Urticaria—Prednisone—psoriatic arthritis	0.00151	0.00168	CcSEcCtD
Disopyramide—Headache—Triamcinolone—psoriatic arthritis	0.00151	0.00168	CcSEcCtD
Disopyramide—Headache—Methylprednisolone—psoriatic arthritis	0.0015	0.00168	CcSEcCtD
Disopyramide—Body temperature increased—Prednisone—psoriatic arthritis	0.0015	0.00168	CcSEcCtD
Disopyramide—Diarrhoea—Betamethasone—psoriatic arthritis	0.00149	0.00166	CcSEcCtD
Disopyramide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00149	0.00166	CcSEcCtD
Disopyramide—Hypotension—Methotrexate—psoriatic arthritis	0.00148	0.00165	CcSEcCtD
Disopyramide—Dizziness—Dexamethasone—psoriatic arthritis	0.00144	0.00161	CcSEcCtD
Disopyramide—Dizziness—Betamethasone—psoriatic arthritis	0.00144	0.00161	CcSEcCtD
Disopyramide—Insomnia—Methotrexate—psoriatic arthritis	0.00144	0.0016	CcSEcCtD
Disopyramide—Nausea—Triamcinolone—psoriatic arthritis	0.00143	0.00159	CcSEcCtD
Disopyramide—Paraesthesia—Methotrexate—psoriatic arthritis	0.00143	0.00159	CcSEcCtD
Disopyramide—Nausea—Methylprednisolone—psoriatic arthritis	0.00142	0.00159	CcSEcCtD
Disopyramide—Dyspnoea—Methotrexate—psoriatic arthritis	0.00142	0.00158	CcSEcCtD
Disopyramide—Somnolence—Methotrexate—psoriatic arthritis	0.00141	0.00157	CcSEcCtD
Disopyramide—Dyspepsia—Methotrexate—psoriatic arthritis	0.0014	0.00156	CcSEcCtD
Disopyramide—Vomiting—Dexamethasone—psoriatic arthritis	0.00139	0.00155	CcSEcCtD
Disopyramide—Vomiting—Betamethasone—psoriatic arthritis	0.00139	0.00155	CcSEcCtD
Disopyramide—Decreased appetite—Methotrexate—psoriatic arthritis	0.00138	0.00154	CcSEcCtD
Disopyramide—Rash—Dexamethasone—psoriatic arthritis	0.00138	0.00153	CcSEcCtD
Disopyramide—Rash—Betamethasone—psoriatic arthritis	0.00138	0.00153	CcSEcCtD
Disopyramide—Dermatitis—Betamethasone—psoriatic arthritis	0.00137	0.00153	CcSEcCtD
Disopyramide—Dermatitis—Dexamethasone—psoriatic arthritis	0.00137	0.00153	CcSEcCtD
Disopyramide—Fatigue—Methotrexate—psoriatic arthritis	0.00137	0.00153	CcSEcCtD
Disopyramide—Headache—Betamethasone—psoriatic arthritis	0.00137	0.00152	CcSEcCtD
Disopyramide—Headache—Dexamethasone—psoriatic arthritis	0.00137	0.00152	CcSEcCtD
Disopyramide—Asthenia—Prednisone—psoriatic arthritis	0.00136	0.00152	CcSEcCtD
Disopyramide—Pain—Methotrexate—psoriatic arthritis	0.00136	0.00151	CcSEcCtD
Disopyramide—Pruritus—Prednisone—psoriatic arthritis	0.00134	0.0015	CcSEcCtD
Disopyramide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00131	0.00146	CcSEcCtD
Disopyramide—Diarrhoea—Prednisone—psoriatic arthritis	0.0013	0.00145	CcSEcCtD
Disopyramide—Nausea—Dexamethasone—psoriatic arthritis	0.0013	0.00145	CcSEcCtD
Disopyramide—Nausea—Betamethasone—psoriatic arthritis	0.0013	0.00145	CcSEcCtD
Disopyramide—Urticaria—Methotrexate—psoriatic arthritis	0.00126	0.00141	CcSEcCtD
Disopyramide—Dizziness—Prednisone—psoriatic arthritis	0.00126	0.0014	CcSEcCtD
Disopyramide—Body temperature increased—Methotrexate—psoriatic arthritis	0.00126	0.0014	CcSEcCtD
Disopyramide—Vomiting—Prednisone—psoriatic arthritis	0.00121	0.00135	CcSEcCtD
Disopyramide—Rash—Prednisone—psoriatic arthritis	0.0012	0.00134	CcSEcCtD
Disopyramide—Dermatitis—Prednisone—psoriatic arthritis	0.0012	0.00133	CcSEcCtD
Disopyramide—Headache—Prednisone—psoriatic arthritis	0.00119	0.00133	CcSEcCtD
Disopyramide—Asthenia—Methotrexate—psoriatic arthritis	0.00114	0.00127	CcSEcCtD
Disopyramide—Nausea—Prednisone—psoriatic arthritis	0.00113	0.00126	CcSEcCtD
Disopyramide—Pruritus—Methotrexate—psoriatic arthritis	0.00112	0.00125	CcSEcCtD
Disopyramide—Diarrhoea—Methotrexate—psoriatic arthritis	0.00109	0.00121	CcSEcCtD
Disopyramide—Dizziness—Methotrexate—psoriatic arthritis	0.00105	0.00117	CcSEcCtD
Disopyramide—Vomiting—Methotrexate—psoriatic arthritis	0.00101	0.00113	CcSEcCtD
Disopyramide—Rash—Methotrexate—psoriatic arthritis	0.001	0.00112	CcSEcCtD
Disopyramide—Dermatitis—Methotrexate—psoriatic arthritis	0.001	0.00112	CcSEcCtD
Disopyramide—Headache—Methotrexate—psoriatic arthritis	0.000995	0.00111	CcSEcCtD
Disopyramide—Nausea—Methotrexate—psoriatic arthritis	0.000943	0.00105	CcSEcCtD
